Publication List

This is a list of publications by AZCC past and present members that made use of the PSS as it developed over the years (2003-2008).

We gratefully acknowledge the support by NCI that made all this work possible.

If your publication does not appear here, please notify Dr. George Tsaprailis.


1. Alderton AL, Faustman C, Liebler DC, and Hill DW. Induction of redox instability of bovine myoglobin by adduction with 4-hydroxy-2-nonenal, Biochemistry. 2003. 42:4398-4405.

2. Jones JA, Kaphalia L, Moslen MT, and Liebler DC. Proteomic characterization of metabolism, protein adducts and hepatobiliary injury in rats exposed to 1,1-dichloroethylene and diclofenac. Chem. Res. Toxicol. 2003. 16:1306-1317.

3. Liebler DC. Analysis of protein modifications with LC-MS and the SALSA algorithm: New tools for toxicology. Exp. Lung Res. 2003. 29 (Suppl. 1):88-92.

4. Mason DE. and Liebler DC. Quantitative analysis of modified proteins by LC-MS-MS of peptides labeled with phenyl isocyanate, J. Proteome Res. 2003. 2:265-272.

5. Sachs NA and Vaillancourt RR. Cyclin-Dependent 11(p110) Activity in the Absence of CK2, Biochimica et Biophysica Acta. 2003. 1624 (1-3):98-108.

6. Shi J, Feng Y, Goulet AC, Vaillancourt RR, Sachs N A, Hershey JW, and Nelson MA. The p34cdc2-related cyclin-dependent kinase 11 interacts with the p47 subunit of eukaryotic initiation factor 3 during apoptosis. J Biol Chem. 2003. 278:5062-5071.

7. Udayakumar TS, Chen ML, Bair EL, von Bredow DC, Cress AE, Nagle RB, and Bowden GT. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration. Cancer Res. 2003. 63:2292-2299.

8. Kalaitzis JA, Izumikawa M, Xiang L, Hertweck C, and Moore BS. Mutasynthesis of Enterocin and Wailupemycin Analogues J. Am. Chem. Soc. 2003. 125:9290-9291.

9. Bernstein H, Payne CM, Kunke K, Crowley-Weber CL, Waltmire CN, Dvorakova K, Holubec H, Bernstein C, Vaillancourt RR, Raynes DA, Guerriero V, and Garewal H. A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis. 2004. 25:1-24.

10. Nyman DW, Stratton MS, Kopplin MJ, Dalkin BL, Nagle RB, and Gandolfi AJ. Selenium and selenomethionine levels in prostate cancer patients. Cancer Detect. Prev. 2004. 28:8-16.

11. Sachs NA and Vaillancourt RR. Cyclin-dependent kinase 11p110 and casein kinase 2 (CK2) inhibit the interaction between tyrosine hydroxylase and 14-3-3. J. Neurochem. 2004. 88:51-62.

12. Mikolajczyk M, and Nelson MA. Regulation of stability of cyclin-dependent kinase CDK11p110 and a caspase-processed form, CDK11p46, by Hsp90. Biochem. J. 2004. 384:461-467.

13. Bair EL, Chen M-L, McDaniel K, Sekigushci K, Cress AE, Nagle RB, and Bowden GT. Membrane-type-1 matrix metalloprotease (MT1-MMP) cleaves laminin-10 and promotes prostate cancer cell migration. Neoplasia. 2005. 7(4):380-389.

14. Zakharyan RA, Tsaprailis G, Chowdhury UK, Hernadez A and Aposhian HV. Interactions of Sodium Selenite, Glutathione, Arsenic Species, and Omega Class Human Glutathione Transferase. Chem. Res. Tox. 2005. 18 (8):1287-1295.

15. Xie L, Tsaprailis G, and Chen QM. Proteomic Identification of Insulin-Like Growth Factor Binding Protein-6 Induced by Sublethal H2O2 Stress from Human Diploid Fibroblasts. Mol. Cell Proteomics. 2005. 4:1273-1283.

16. Derbyshire ZE, Halfter UM, Heimark RL, and Vaillancourt RR. Angiotensin II stimulated transcription of cyclooxygenase II is regulated by a novel kinase cascade involving Pyk2, MEKK4, and annexin II. Mol. Cell Biochem. 2005. 271 (1-2):77-90.

17. Kirkpatrick DD, Weldon SF, Tsaprailis G, Liebler DC, and Gandolfi AJ. Proteomic Identification of ubiquitinated proteins from human cells expressing His-tagged ubiquitin. Proteomics. 2005. 5(8):2104-2111.

18. Falsey RR, Marron MT, Kaml GB, Kamal GM, Shirahatti N, Mahadevan D, Gutanilaka AAL, and Whitesell L. Actin microfilament aggregation induced by withaferin A is mediated by annexin II. Nat. Chem. Biol. 2006. 2(1):33-38.

19. Baker AF, Dragovich T, Tate WR, Ramanathan R, Roe D, Hsu C-H, Kirkpatrick DL, and Powis G. The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazoyl disulfide) decreases thioredoxin-1 and VEGF levels in patient plasma. J. Lab. Clin. Med. 2006. 147(2):83-90.

20. Zhilina ZV, Ziemba AJ, Nielsen PE, and Ebbinghaus SW. PNA-nitrogen mustard conjugates are effective suppressors of HER-2/neu and biological tools for recognition of PNA/DNA interactions. Bioconj. Chem. 2006. 17:214-222.

21. Cai M, Tsaprailis G, Bordelon S, Qu H, Trivedi D, and Hruby VJ. Cell signaling of melanocortin receptor I by mass spectrometric analysis. J. Pep. Sci. 2006. 12:206.

22. Ignatenko NA, Yerushalmi HF, Watts GS, Futscher BW, Stringer DE, Marton LJ, and Gerner EW. Pharmacogenomics of the Polyamine Analog, CGC-11093, in the Colon Adenocarcinoma Cell Line HCT116. Tech. Cancer Res. & Treat. 2006. 5(6):553-564.

23. Labenski MT, Fisher AA, Tsaprailis G, Monks TJ, and Lau SS. Identifying site-specific chemical modifications of urinary excreted protein using a proteomics approach. FASEB J. 2006. 20 (4): A66.

24. Aposhian HV, Avram MD, Tsaprailis G, Chowdhury UK. The king of poison, the poison of kings, and the bane of investigators. Chem. Res. Toxicol. 2006. 19(12):1680-1680.

25. Wen F, VanEtten, HD, Tsaprailis G, and Hawes MC. Extracelluler Proteins in Pisum sativum L. Root Tip and Border Cell Exudes. Plant Phys. 2007. 143:773-783.

26. Lantz RC, Lynch BJ, Boitano S, Poplin GS, Littau S, Tsaprailis G, and Burgess JL. Pulmonary biomarkers based on alterations in protein expression following exposure to arsenic. Environ. Health Perspect. 2007. 115(4):586-591.

27. Weichsel A, Brailey JL, and Montfort WR. Buried S-Nitrosocysteine Revealed in Crystal Structures of Human Thioredoxin. Biochemistry. 2007. 46:1219-1227.

28. Wozniak RJ, Klimecki WT, Lau SS, Feinstein Y, and Futscher BW. 5-aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene. 2007. 26:77-90.

29. Hruby VJ, Cai M, Dedek M, and Tsaprailis G. Peptide and non-peptide mimetixs utilize different pathways for signal transduction. Biopolymers. 2007. 88(4): 520-520.

30. Dedek M, Yang Y, Palmer E, Tsaprailis G, Mayorov A, Trivedi D, and Hruby VJ. Rational drug design for GPCR: Molecular mechanism of agonist mediated cell signaling for melanocortin receptors. Biopolymers. 2007. 88(4):593-593.

31. Wilson JW, Ott CM, Bentrup KHZ, Ramamurthy R, Quick L, Porwolli S, Cheng P, McClelland M, Tsaprailis G, Radabaugh T, Hunt A, Fernandez D, Richter E, Shah M, Kilcyne M, Joshi L, Neiman-Gonzalez M, Hing S, Parra M, Dumars P, Norwood K, Bober R, Devich J, Ruggles A, Goulart C, Rupert M, Stodieck L, Stafford P, Catella L, Schurr MJ, Buchanan K, Morici L, McCracken J, Allen P, Baker-Coleman C, Hammond T, Vogel J, Nelson R, Pierson DL, Stefanyshyn-Piper HM, and Nickerson CA. Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq. PNAS. 2007. 104 (41):16299-16304.

32. Demetriou MC, Stylianou P, Andreou M, Yiannikouri O, Tsaprailis G, Cress AE, and Skourides P. Spatially and temporaly regulated a6 integrin cleavage during Xenopus laevis development. Biochem. Biophys. Res. Comm. 2008. 366 (3):779-785.

33. Zhang J, Tsaprailis G, and Bowden GT. Nucleolin Stabilizes Bcl-XL mRNA in Response to UVA Irradiation. Cancer Res. 2008. 68:1046-1054.

34. Xie LF, Xu BB, Pandey R, Tsaprailis GT and Chen QM. Genomic and Proteomic Profiles of Oxidative Stress in Normal Human Diploid Fibroblasts. Biogerontology. 2008. In press.

35. Uemura T, Yerusahlmi HF, Tsaprailis G, Stringer DE, Pastorian KE, Hawel L, Byus CV, and Gerner EW. Identification and Characterization of a Diamine Exprter in Colon Epithelial Cells. J. Biol. Chem. 2008. In press.